Search

Author/Creator Van Assche, G

1. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease. Issue 8 (21st February 2006)

Authors:
Reinisch, W; Hommes, D W; Van Assche, G; Colombel, J-F; Gendre, J-P; Oldenburg, B; Teml, A; Geboes, K; Ding, H; Zhang, L; Tang, M; Cheng, M; van Deventer, S J H; Rutgeerts, P; Pearce, T
Journal:
Gut
Issue:
Volume 55:Issue 8(2006)
Page Start:
1138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Issue 11 (7th April 2006)

Authors:
Van Assche, G; Sandborn, W J; Feagan, B G; Salzberg, B A; Silvers, D; Monroe, P S; Pandak, W M; Anderson, F H; Valentine, J F; Wild, G E; Geenen, D J; Sprague, R; Targan, S R; Rutgeerts, P; Vexler, V; Young, D; Shames, R S
Journal:
Gut
Issue:
Volume 55:Issue 11(2006)
Page Start:
1568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DOP47 Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase 3 UNIFI maintenance study. (25th January 2019)

Authors:
Van Assche, G; Targan, S R; Baker, T; O'Brien, C D; Zhang, H; Johanns, J; Szapary, P; Marano, C; Leong, R W; Rowbotham, D; Hisamatsu, T; Danese, S; Sands, B E; Peyrin-Biroulet, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. DOP54 Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial. (25th January 2019)

Authors:
Danese, S; Sands, B E; O'Brien, C D; Zhang, H; Johanns, J; Sloan, S; Izanec, J; Szapary, P; Marano, C; Leong, R W; Rowbotham, D; Targan, S R; Van Assche, G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗